Retatrutide
Triple agonist research peptide · From 10mg
99%+ Pure$120
Product Description
Retatrutide is a novel triple agonist research peptide that simultaneously targets GLP-1, GIP, and glucagon receptors. It has gained significant attention in the research community for its unique multi-receptor mechanism of action. Studies have explored its potential applications in metabolic research, making it one of the most discussed peptides in current scientific literature.
Expert Insight
“Triple agonists represent the cutting edge of metabolic research peptides. Retatrutide's simultaneous activation of three distinct pathways offers researchers a sophisticated tool for exploring complex metabolic interplay. The peptide's mechanism mirrors natural signaling cascades, providing unique insights into multi-target pharmacology.”
Research Pairing Suggestions
Researchers studying comprehensive metabolic optimization commonly pair these because Retatrutide's triple-agonist mechanism (GLP-1/GIP/glucagon) complements 5-Amino-1MQ's NAD+-boosting metabolic enhancement.
Research Highlights
Triple-receptor agonism (GLP-1, GIP, glucagon) in a single peptide
Extensively studied in peer-reviewed metabolic research
Represents next-generation approach to multi-target investigation
This calculator is a math tool only. It does not provide medical advice. Vital Peptides Labs sells research peptides for laboratory and research use only. Users are strongly encouraged to read the linked research, consult qualified professionals, and draw their own conclusions before making any decisions.
Reconstitution Calculator— Retatrutide
Research Literature — Retatrutide
The following is a summary of published research literature. This information is provided for educational reference only and does not constitute medical advice or research amount guidance.
Research Amounts in Literature
In published Phase 2 clinical trials, researchers administered Retatrutide at doses of 0.5–12 mg per week with dose escalation protocols. Research commonly starts at lower doses (1–4 mg) with titration upward.
Frequency Protocols in Research
Published literature on Retatrutide reports weekly subcutaneous administration protocols in clinical research settings, with dose escalation every 4 weeks.
Reconstitution Concentrations in Research
Published literature reports reconstitution of 10–20 mg lyophilized vials in 2–3 mL bacteriostatic water, yielding concentrations of 3.3–10 mg/mL. Using 2 mL for a 10 mg vial (5 mg/mL) is the most commonly referenced standard for GLP-1 agonists.
Typical Syringe Ranges in Research
At common research concentrations (e.g., 5 mg/mL), typical administration volumes for weekly protocols range from 10–120 units (0.1–1.2 mL).
Retatrutide
Add to your order
Pairs Well With
You'll Also Need
3mL / 23G Reconstitution Syringe
For mixing bacteriostatic water into lyophilized peptide vials
~$10–15
Buy on Amazon31G Research Syringe
For precise subcutaneous administration in research protocols
~$12–18
Buy on AmazonAlcohol Prep Pads
For sterilizing vial stoppers and work surfaces
~$5–8
Buy on AmazonBacteriostatic Water (10mL)
Sterile water with 0.9% benzyl alcohol for reconstitution
$10
ViewThis product is intended strictly for laboratory research and development purposes only. Not for human consumption, medical, veterinary, or household use. By purchasing this product, you confirm that you are at least 21 years of age and that the product will be used solely for legitimate research purposes.